Key takeaways Ozempic, FDA approved to manage Type 2 diabetes, works by mimicking a hormone that helps regulate blood sugar and can also reduce appetite
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed in the UK for type 2 diabetes management and, more recently, for weight management in adults with obesity
The FDA issued warning letters in March 2026 (sourced: FDA.gov press announcement, March 3, 2026) targeting companies that obscured this distinction
Inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) NOX is a plasma membrane-bound enzymatic complex that catalyzes the production of superoxide from oxygen and NADPH and has been involved in innate immune defense against microbes (39)
During your consultation, we evaluate your health history, metabolic factors, and weight-loss goals to determine whether GLP-1 therapy may be appropriate for you
RPS improved free fatty acid levels and conjugated bile acids that are linked to metabolic health
